| Net income (loss) | -29.26M |
| Depreciation and other amortization | |
| (Decrease) increase in fair value of warrants | -1.12M |
| Stock based compensation | 521.67K |
| Accounts receivable | -35.07M |
| Accrued interest on short-term investments | |
| Prepaid expenses | -1.84M |
| Other assets | 1.35M |
| Deferred income taxes, net | |
| Accounts payable, accrued expenses, and other current liabilities | |
| Other liabilities | -63.17K |
| Net cash used in operating activities | -90.91M |
| Capital expenditures | -11K |
| Proceeds from maturity of short term investments | |
| Purchases of short term investments | |
| Net cash provided by (used in) investing activities | -11K |
| Net proceeds from exercise of warrants and options | 0 |
| Repurchase of common stock | |
| Net cash provided by financing activities | -1.29M |
| Net decrease in cash and cash equivalents | -92.22M |
| Cash and cash equivalents at beginning of period | 112.71M |
| Cash and cash equivalents at end of period | 20.49M |
| Reclass of common stock warrant liability to additional paid-in capital upon exercise | |